EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human T Cell Responses to Flavivirus Vaccines

David Wullimann, Hans-Gustaf Ljunggren

European Journal of Immunology · 2025-08 · 55 (8)

DOI: 10.1002/eji.70027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 17.08.2025. Verfasst von David Wullimann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center For Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Flavivirus, Flavivirus Infections, Viral Vaccines, T-Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flaviviruses are major human pathogens that continue to pose a global health threat, and vaccination is an effective strategy to protect against disease from several flaviviruses. Flavivirus vaccines are believed to confer protection primarily through antibody responses; however, the role of T cells in vaccine immunity remains less explored despite demonstrated contribution in the response to natural infection. This review examines T cell responses induced by licensed or developing flavivirus vaccines, their contribution to protection, and key findings highlighting the importance of cellular immunity. We discuss the role of memory T cells, including CD4+ and CD8+ subsets, in flavivirus vaccine‐induced immunity and compare the immunogenicity of live attenuated versus inactivated vaccines. We also discuss the significance of T cell immunity, cross‐reactivity, and vaccine platform design in shaping durable and broad protection. Additionally, we broaden the discussion toward other human RNA viruses, including the influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). A better understanding of the role of T cell immunity will be essential for optimizing the use of current flavivirus vaccines and developing next‐generation approaches capable of providing long‐lasting immunity against emerging and re‐emerging flavivirus threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavivirusFlavivirus InfectionsViral VaccinesT-LymphocytesHumansCross ReactionsSARS-CoV-2Immunity, CellularCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesAnimalsCOVID-19Immunologic MemoryVaccines, Attenuated

Stichwörter der Autor:innen

CD4+ T cellsCD8+ T cellsJapanese encephalitis virusZika virusdengue virusflavivirusimmune memorytick‐borne encephalitis virusvaccinationviral protectionyellow fever virus

Substanzen

Viral VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • Center For Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Zitieren

APA

Wullimann, D., & Ljunggren, H. G. (2025). Human T Cell Responses to Flavivirus Vaccines. European Journal of Immunology, 55(8). https://doi.org/10.1002/eji.70027

Vancouver

Wullimann D, Ljunggren HG. Human T Cell Responses to Flavivirus Vaccines. European Journal of Immunology. 2025;55(8). doi:10.1002/eji.70027

BibTeX
@article{Wullimann2025,
  author = {Wullimann, David and Ljunggren, Hans-Gustaf},
  title = {Human T Cell Responses to Flavivirus Vaccines},
  journal = {European Journal of Immunology},
  year = {2025},
  volume = {55},
  number = {8},
  doi = {10.1002/eji.70027}
}
Kostenlos starten →